About the Event
Aruna Bio has developed an innovative neural anti-inflammatory and neuro-modulator that naturally crosses the Blood/Brain Barrier. This represents a major breakthrough in treating Central Nervous System (CNS) diseases like Parkinson’s, Alzheimer’s, Multiple Sclerosis, and acute events like Strokes and Traumatic Brain Injuries.
Join our panel discussion with:
- Mason “Skip” Irving: Board Member of the Michael J. Fox Foundation for Parkinson’s Research
- John Bishai, PhD: Managing Director – Healthcare Investment Banking – Bank of America Securities
- Steven From, CEO, Aruna Bio
They’ll discuss the science that allows Aruna’s platform to cross the blood/brain barrier, its native therapeutic benefits, and how it can be used to deliver specialized neural therapeutics directly to the site of action.
Sign up today to learn what this breakthrough means for the for the millions of people suffering from some of the most debilitating diseases we face today.